Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1982-10-28
1984-10-16
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
A61K 31485
Patent
active
044774575
ABSTRACT:
Nalbuphine or nalmetrene can be administered orally so as to effect appetite suppression in mammals.
REFERENCES:
patent: 3393197 (1968-07-01), Pachter et al.
patent: 3814768 (1974-06-01), Fishman
patent: 3896226 (1975-07-01), Fishman
patent: 4217353 (1980-08-01), Smith
patent: 4322426 (1982-03-01), Hermann et al.
patent: 4366159 (1982-12-01), Magruder
Miller, Am J. Hosp. Pharm., 37, 942-949 (1980).
Holtzman, J. Pharmacol. Exp. Ther., 189, 51-60 (1974).
Holtzman, Life Sciences, 16, 1465-1470 (1975).
E. I. Du Pont de Nemours and Company
Robinson Douglas W.
LandOfFree
Method for inducing anorexia using nalmetrene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inducing anorexia using nalmetrene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inducing anorexia using nalmetrene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1945125